April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Comparison of uveal melanoma prognostication test results of the 'paired' intraocular biopsy with the subsequently enucleated eye
Author Affiliations & Notes
  • Sarah E Coupland
    Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
  • Helen Kalirai
    Molecular and Clinical Cancer Medicine, University of Liverpool, Liverpool, United Kingdom
  • Vivian Ho
    Ophthalmology, Royal Liverpool University Hospital, Liverpool, United Kingdom
  • Bertil E Damato
    Ophthalmology, University of California, San Francisco, CA
  • Heinrich Heimann
    Ophthalmology, Royal Liverpool University Hospital, Liverpool, United Kingdom
  • Footnotes
    Commercial Relationships Sarah Coupland, None; Helen Kalirai, None; Vivian Ho, None; Bertil Damato, None; Heinrich Heimann, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5079. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sarah E Coupland, Helen Kalirai, Vivian Ho, Bertil E Damato, Heinrich Heimann; Comparison of uveal melanoma prognostication test results of the 'paired' intraocular biopsy with the subsequently enucleated eye. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5079.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To compare the accuracy of genetic results for chromosome 3 aberrations from a fine needle aspiration biopsy (FNAB) with those from a subsequent enucleation specimen in uveal melanoma (UM) patients who underwent prognostic testing in Liverpool, UK.

Methods: UM patients who underwent routine genetic testing for prognostic purposes of an initial biopsy specimen and a subsequent enucleation specimen between 2010 and 2013 were included in this study. Depending on DNA yield, specimens underwent molecular testing by either microsatellite analysis (MSA) or multiplex ligation dependent probe amplification (MLPA). Data for chromosome 3 status were then compared between the ‘paired’ tumour samples. During this period of 3 years, 111 UM patients seen at the Liverpool Ocular Oncology Centre had undergone genetic tumour testing by MSA, and an additional 429 patients by MLPA.

Results: Paired biopsy and enucleation data were available for 17 patients (5 female and 12 male). The median largest basal diameter of the tumours was 15.8mm (range 9.2-20.4mm). The median follow-up time was 1.5 years (range 0.15-3.3 years). Epithelioid cells were present in nine tumours. Seven biopsy specimens were analysed by MLPA, the remainder being analysed by MSA. All seventeen enucleation specimens were analysed by MLPA for chromosomes 1p, 3, 6 and 8. Chromosome 3 data showed complete concordance between the biopsy samples and enucleated eyes in all 17 cases. Eight patients were classified as monosomy 3 (M3) and nine as disomy 3. These results were incorporated for patient further management purposes in the Liverpool Uveal Melanoma Prognostication Online model. During the follow-up period, one of the eight patients with a tumour classified as M3, died at the time of data analysis.

Conclusions: It is feasible to obtain DNA of sufficient quality and quantity from FNAB specimens of UM with no loss of prognostic accuracy compared with DNA extracted from the enucleated eyes. In this cohort, tumour cell- or clonal heterogeneity did not play a major role in affecting the results.

Keywords: 745 uvea • 589 melanoma • 539 genetics  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×